Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study.
Sakura IizumiAtsuo TakashimaYukiya NaritaMasahiro TajikaKei MuroSadayuki KawaiHirofumi YasuiTomohiro MatsushimaDaisuke TakahariKengo NagashimaNarikazu BokuPublished in: Cancer chemotherapy and pharmacology (2017)
Taxane monotherapy after DCS failure had acceptable toxicities but was ineffective in AGC patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- combination therapy
- newly diagnosed
- open label
- locally advanced
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- clinical trial
- squamous cell carcinoma
- metastatic breast cancer
- patient reported outcomes
- patient reported
- double blind
- quantum dots